How gut and liver lymph nodes shape pancreatic immunity
Immune crosstalk through shared LN drainage in the digestive system
This work looks at whether lymph nodes shared by the gut, liver, and pancreas change immune cells in ways that could trigger or protect people from type 1 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11330564 on NIH RePORTER |
What this research studies
You can think of lymph nodes as meeting places where immune cells learn what to attack or ignore; this project focuses on lymph nodes that drain the pancreas along with the duodenum and liver. Researchers will track dendritic cells that carry pancreatic proteins into those shared lymph nodes and describe how they influence T cells that can damage or protect insulin-producing beta cells. The team will test how gut or liver disturbances, such as infection or dietary changes, alter those lymph node environments and the resulting pancreatic immune responses using laboratory models and tissue analyses. The goal is to determine whether this cross-talk helps start, worsen, or prevent autoimmune diabetes.
Who could benefit from this research
Good fit: People with type 1 diabetes or individuals identified as high risk for developing type 1 diabetes (for example, by antibody testing) would be most relevant to this line of research.
Not a fit: People with type 2 diabetes, conditions unrelated to pancreatic autoimmunity, or those seeking immediate clinical treatments are unlikely to receive direct benefit from this basic immunology work.
Why it matters
Potential benefit: If successful, the work could reveal targets for new therapies or prevention strategies that steer immune responses away from attacking insulin-producing cells.
How similar studies have performed: Related lab and animal studies have shown that lymph node dendritic cells can direct autoimmune responses, but applying this concept to pancreas–gut–liver drainage and type 1 diabetes is a relatively new direction.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Esterhazy, Daria — University of Chicago
- Study coordinator: Esterhazy, Daria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.